Today’s Watch List : Vale S.A. (NYSE:VALE), GlaxoSmithKline plc (NYSE:GSK), Delta Air Lines, Inc. (NYSE:DAL), U.S. Silica Holdings, Inc. (NYSE:SLCA), MBII

Shares of Brazilian metals and mining company Vale S.A. (NYSE:VALE) rose for the second consecutive day Tuesday after Brazil’s presidential election on Sunday resulted in a runoff to be held on October 26. Incumbent Dilma Rousseff received 41.59% of the votes, while challenger Aecio Neves received 33.54%. Vale S.A. (NYSE:VALE) belongs to Basic Materials sector. Its net profit margin is 1.40% and weekly performance is … Continue reading Today’s Watch List : Vale S.A. (NYSE:VALE), GlaxoSmithKline plc (NYSE:GSK), Delta Air Lines, Inc. (NYSE:DAL), U.S. Silica Holdings, Inc. (NYSE:SLCA), MBII

Shining on Major News : Regions Financial Corporation (NYSE:RF), Altria Group Inc. (NYSE:MO), Alpha Natural Resources, Inc. (NYSE:ANR), SJW Corp. (NYSE:SJW), AIXG

Regions Financial Corp (NYSE:RF) last posted its quarterly earnings results on Tuesday, July 22nd. The company reported $0.21 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.21. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter last year, the company posted $0.18 earnings per share. Regions Financial Corp’s … Continue reading Shining on Major News : Regions Financial Corporation (NYSE:RF), Altria Group Inc. (NYSE:MO), Alpha Natural Resources, Inc. (NYSE:ANR), SJW Corp. (NYSE:SJW), AIXG

Active Stocks : Microsoft Corporation (NASDAQ:MSFT), Ericsson (NASDAQ:ERIC), Norcraft Companies, Inc. (NYSE:NCFT), Telecom Argentina S.A. (NYSE:TEO), Limoneira Company (NASDAQ:LMNR)

Microsoft Corporation (NASDAQ:MSFT) responded by saying that the Surface Pro 3’s dual functionality as a tablet and a laptop is perfect for businesses, and said it had a number of major business customers. Microsoft shares closed trading down 1.99% to $45.85 on Thursday. Microsoft Corporation (NASDAQ:MSFT) belongs to Technology sector. Its net profit margin is 25.40% and weekly performance is 0.20%. On last trading day … Continue reading Active Stocks : Microsoft Corporation (NASDAQ:MSFT), Ericsson (NASDAQ:ERIC), Norcraft Companies, Inc. (NYSE:NCFT), Telecom Argentina S.A. (NYSE:TEO), Limoneira Company (NASDAQ:LMNR)

Morning Watch List : Hecla Mining Co. (NYSE:HL), Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL), Vodafone Group Plc (ADR) (NASDAQ:VOD), Exlservice Holdings, Inc. (NASDAQ:EXLS), AAPL

Hecla Mining Company (NYSE:HL) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a note issued to investors on Tuesday. Hecla Mining Co. (NYSE:HL) belongs to Basic Materials sector. Its net profit margin is -3.10% and weekly performance is -8.88%. On last trading day company shares ended up $2.36. Hecla Mining Co. (NYSE:HL) distance from 50-day simple moving average (SMA50) is … Continue reading Morning Watch List : Hecla Mining Co. (NYSE:HL), Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL), Vodafone Group Plc (ADR) (NASDAQ:VOD), Exlservice Holdings, Inc. (NASDAQ:EXLS), AAPL

Microsoft Looking For No Email Attachments

Microsoft Corporation (NASDAQ MSFT) wants to make things a little bit easier for it’s email users. The company’s Outlook Web App simplifies everything by allowing users to send links to attachments stored on OneDrive for Business.Microsoft thinks the process of attaching, opening, modifying, and re-sending documents takes too much time. The new Outlook Web and OneDrive for Business apps will make sharing and collaborating that … Continue reading Microsoft Looking For No Email Attachments

Biotech Stock Finance Bio Tech

Biotech Stock News: Regeneron’s Eylea Gets An Important Approval From FDA

Good news flowed in at Regeneron Pharmaceuticals (REGN) when the FDA cleared the company’s highly successful injectable eye drug for macular edema following retinal vein occlusion (RVO), a common retinal vascular disorder. Approval for the broad RVO indication includes sub-indications like, macular edema following branch retinal vein occlusion (BRVO) and macular edema following central retinal vein occlusion (CRVO). We remind investors that Eylea is already … Continue reading Biotech Stock News: Regeneron’s Eylea Gets An Important Approval From FDA